1.
Kiss, LS ; Papp, M ; Lovasz, BD ; Vegh, Z ; Golovics, PA ; Janka, E ; Varga, E ; Szathmari, M ; Lakatos, PL
High-sensitivity C-reactive Protein for Identification of Disease Phenotype, Active Disease, and Clinical Relapses in Crohn's Disease: A Marker for Patient Classification?
INFLAMMATORY BOWEL DISEASES 18 : 9 pp. 1647-1654. , 8 p. (2012)
DOI WoS Scopus PubMed
Publication:1718155 Validated Core Citing Journal Article (Article ) Scientific
Citing papers: 82 | Independent citation: 75 | Self citation: 7 | Unknown citation: 0 | Number of citations in WoS: 75 | Number of citations in Scopus: 74 | WoS/Scopus assigned: 80 | Number of citations with DOI: 80
Article (Journal Article) | Scientific[1718155] [Validated]
All citations+mentions: 82, External citations: 75, Self citations: 7, Unhandled citations: 0
2.
Miheller, P ; Kiss, LS ; Lorinczy, K ; Lakatos, PL ✉
Anti-TNF trough levels and detection of antibodies to anti-TNF in inflammatory bowel disease: are they ready for everyday clinical use?
EXPERT OPINION ON BIOLOGICAL THERAPY 12 : 2 pp. 179-192. , 14 p. (2012)
DOI WoS Scopus PubMed
Publication:1767302 Validated Core Citing Journal Article (Survey paper ) Scientific
Citing papers: 30 | Independent citation: 26 | Self citation: 4 | Unknown citation: 0 | Number of citations in WoS: 21 | Number of citations in Scopus: 26 | WoS/Scopus assigned: 27 | Number of citations with DOI: 26
Survey paper (Journal Article) | Scientific[1767302] [Validated]
All citations+mentions: 30, External citations: 26, Self citations: 4, Unhandled citations: 0
3.
Kiss, LS ; Hungarian IBD Study Group (Collaborative Organization) ; Szamosi, T ; Molnar, T ; Miheller, P ; Lakatos, L ; Vincze, A ; Palatka, K ; Barta, Z ; Gasztonyi, B et al.
Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn’s disease
ALIMENTARY PHARMACOLOGY & THERAPEUTICS 34 : 8 pp. 911-922. , 12 p. (2011)
DOI REAL DEA WoS Scopus PubMed
Publication:1668892 Validated Core Citing Journal Article (Study Group ) Scientific
Citing papers: 160 | Independent citation: 145 | Self citation: 15 | Unknown citation: 0 | Number of citations in WoS: 145 | Number of citations in Scopus: 149 | WoS/Scopus assigned: 154 | Number of citations with DOI: 151
Study Group (Journal Article) | Scientific[1668892] [Validated]
All citations+mentions: 160, External citations: 145, Self citations: 15, Unhandled citations: 0
4.
PRECISE 1 Study Investigators (Collaborative Organization) ; Sandborn, W.J. ✉ ; Feagan, B.G. ; Stoinov, S. ; Honiball, P.J. ; Rutgeerts, P. ; Mason, D. ; Bloomfield, R. ; Schreiber, S.** ; Fabian, H. (Collaborator) et al.
Certolizumab pegol for the treatment of Crohn's disease
NEW ENGLAND JOURNAL OF MEDICINE 357 : 3 pp. 228-238. , 11 p. (2007)
DOI WoS Scopus
Publication:31284121 Validated Core Journal Article (Study Group ) Scientific
Citing papers: 1,008 | Independent citation: 814 | Self citation: 194 | Unknown citation: 0 | Number of citations in WoS: 821 | Number of citations in Scopus: 978 | WoS/Scopus assigned: 1,007 | Number of citations with DOI: 894
Study Group (Journal Article) | Scientific[31284121] [Validated]
All citations+mentions: 1008, External citations: 814, Self citations: 194, Unhandled citations: 0
2026-03-09 12:42